Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Feb;10(1):35-43.
doi: 10.1007/s10194-008-0083-1. Epub 2008 Nov 14.

GERD prevalence in migraine patients and the implication for acute migraine treatment

Affiliations

GERD prevalence in migraine patients and the implication for acute migraine treatment

Bozena J Katić et al. J Headache Pain. 2009 Feb.

Abstract

The objective of this study is to estimate the prevalence of gastroesophageal reflux disease (GERD) and heartburn in migraine patients and examine their use of non-steroidal anti-inflammatory drugs (NSAIDs) or aspirin-containing medications when treating acute migraine attacks. Responses from a web-based survey of migraine patients were matched to the same patient's responses on a general health survey. A total of 1,832 migraineurs (92.0%) were successfully matched. A total of 403 migraineurs (22.0%) reported having diagnosed GERD, 212 (11.6%) reported diagnosed heartburn, and 290 (15.8%) reported reflux symptoms but were undiagnosed. The most common prescription drugs used to treat migraines were triptans. First-line NSAID/aspirin medication use was 10.0% among diagnosed GERD and heartburn patients, 17.8% among undiagnosed patients, and 11.8% among GERD/heartburn-free migraineurs. In conclusion, almost half of migraineurs reported physician-diagnosed GERD and heartburn or symptoms of these conditions. Use of NSAID medications for migraine is fairly common among diagnosed GERD patients and more so for those with undiagnosed GERD symptoms. Physicians should minimize prescribing NSAIDs or NSAID-containing acute migraine medications in this population.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Migraine sample

Similar articles

Cited by

References

    1. Diamond S, Bigal ME, Silberstein S, Loder E, Reed M, Lipton RB. Patterns of diagnosis and acute and preventive treatment for migraine in the United States: results from the American Migraine Prevalence and Prevention study. Headache J Head Face Pain. 2006;47(3):355–363. - PubMed
    1. Cady RK. Diagnosis and treatment of migraine. Clin Cornerstone. 1999;1(6):21–32. doi: 10.1016/S1098-3597(99)90037-6. - DOI - PubMed
    1. Bigal ME, Lipton RB, Stewart WF. The epidemiology and impact of migraine. Curr Neurol Neurosci Rep. 2004;4(2):98–104. doi: 10.1007/s11910-004-0022-8. - DOI - PubMed
    1. Bigal ME, Lipton RB, Holland PR, Goadsby PJ. Obesity, migraine, and chronic migraine: possible mechanisms of interaction. Neurology. 2007;68(21):1851–1861. doi: 10.1212/01.wnl.0000262045.11646.b1. - DOI - PubMed
    1. Kurth T. Associations between migraine and cardiovascular disease. Expert Rev Neurother. 2007;7(9):1097–1104. doi: 10.1586/14737175.7.9.1097. - DOI - PubMed

Publication types

MeSH terms

Substances